Us Pharma And Biotech Summit 2024: Artificial Intelligence And Machine Learning Through The Eyes Of The Fda Part Ii

Tala Fakhouri, Associate Director for Policy Analysis at the FDA, discusses the potential future of AI and machine learning in the pharmaceutical industry and the FDA’s approach to regulating these technologies.